Suntrust Banks’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-2,584
| Closed | -$203K | – | 1326 |
|
|
2019
Q1 | $203K | Buy |
+2,584
| New | +$203K | ﹤0.01% | 1220 |
|
|
2018
Q2 | – | Sell |
-3,594
| Closed | -$370K | – | 1329 |
|
|
2018
Q1 | $370K | Buy |
3,594
+239
| +7% | +$24.6K | ﹤0.01% | 978 |
|
|
2017
Q4 | $287K | Sell |
3,355
-872
| -21% | -$74.6K | ﹤0.01% | 1051 |
|
|
2017
Q3 | $359K | Sell |
4,227
-229
| -5% | -$19.4K | ﹤0.01% | 978 |
|
|
2017
Q2 | $338K | Buy |
4,456
+192
| +5% | +$14.6K | ﹤0.01% | 995 |
|
|
2017
Q1 | $282K | Sell |
4,264
-4,338
| -50% | -$287K | ﹤0.01% | 1049 |
|
|
2016
Q4 | $545K | Buy |
8,602
+124
| +1% | +$7.86K | ﹤0.01% | 963 |
|
|
2016
Q3 | $539K | Sell |
8,478
-244
| -3% | -$15.5K | ﹤0.01% | 936 |
|
|
2016
Q2 | $648K | Buy |
8,722
+218
| +3% | +$16.2K | ﹤0.01% | 854 |
|
|
2016
Q1 | $567K | Buy |
8,504
+3,573
| +72% | +$238K | ﹤0.01% | 888 |
|
|
2015
Q4 | $332K | Buy |
+4,931
| New | +$332K | ﹤0.01% | 1087 |
|
|
2014
Q2 | – | Sell |
-32,151
| Closed | -$1.35M | – | 1560 |
|
|
2014
Q1 | $1.35M | Buy |
+32,151
| New | +$1.35M | 0.01% | 822 |
|